What aldosterone and nitric oxide reveal about hard-to-treat blood pressure

If your blood pressure refuses to come down — even when you’re doing everything right — it may not be a treatment problem.

It may be a diagnosis problem.

Because in a growing number of cases, what looks like stubborn or “resistant” hypertension isn’t random… and it isn’t inevitable.

It’s being driven by underlying systems that aren’t always part of standard evaluations.

Two of the most important — and most overlooked — are a hormone called aldosterone and a molecule your body depends on to relax blood vessels: nitric oxide.

When these two systems fall out of balance, blood pressure can become much harder to control… no matter what else you’re doing.

The adrenal gland hormone that overrides your efforts

Aldosterone doesn’t get as much attention as it should, but in many cases, it acts like a master regulator of blood pressure.

Its job is simple: help your body manage sodium and fluid levels. But when aldosterone levels are too high, that system starts working against you.

Instead of maintaining balance, your body begins holding onto more sodium and water than it should. That increases blood volume, and with it, the pressure inside your arteries.

What makes this especially important is how often it’s overlooked.

For years, excess aldosterone was considered relatively rare. But newer research suggests it may be far more common, especially in people whose blood pressure is difficult to control.

And yet, many people are never specifically evaluated for it.

Which means the underlying driver remains in place… even as medications or lifestyle strategies are adjusted around it.

Targeting aldosterone may help lower blood pressure

This growing focus on aldosterone isn’t just theoretical — it’s starting to change how resistant blood pressure is approached.

In the Phase III BaxHTN trial, researchers tested a medication designed specifically to block aldosterone’s effects.

The results were notable: even in people whose blood pressure had remained high despite multiple medications, targeting this one pathway led to meaningful reductions.

What makes this important isn’t just the drug itself. It’s what the results suggest.

That for some people, blood pressure isn’t simply a matter of needing more treatment…

It’s a matter of targeting the right mechanism. And in many of those cases, aldosterone appears to be a key part of the picture.

The other side of the equation: When blood vessels can’t relax

At the same time, another system is often moving in the opposite direction.

Nitric oxide is what allows your blood vessels to relax and widen. It helps keep blood flowing smoothly and reduces resistance inside the arteries.

But as we get older and especially under conditions like stress, inflammation or metabolic imbalance, nitric oxide production can decline.

When that happens, blood vessels stay tighter than they should. And this is where the bigger picture comes into focus.

In many people, these two issues don’t happen in isolation.

You can have:

• Increased fluid volume driven by aldosterone
• And reduced vessel flexibility due to low nitric oxide

In other words, more pressure pushing through a system that’s less able to accommodate it.

That combination alone can make blood pressure especially difficult to bring down.

Supporting the systems behind blood pressure

Once you start looking at blood pressure through this lens — fluid balance on one side, vessel flexibility on the other — the next step isn’t just doing more…

It’s supporting the right systems. One area that deserves attention is nitric oxide production.

Nitric oxide is a naturally produced molecule the body produces that helps blood vessels relax and supports healthy circulation.

Laboratory studies using animal models and human adrenal cells have shown that nitric oxide can inhibit aldosterone production under certain conditions. Small human studies have also found that when nitric oxide production is blocked, aldosterone levels increase.

Together, these findings suggest a regulatory balance in the body: nitric oxide supports blood vessel relaxation, while excess aldosterone promotes fluid retention and increased blood pressure.

How to support nitric oxide naturally

While nitric oxide naturally declines with age, your body still has the ability to produce it—especially when given the right building blocks.

Certain foods are rich in natural compounds that the body can convert into nitric oxide. These include:

• Beets
• Spinach
• Arugula
• Celery

Beets, in particular, are one of the most well-researched dietary sources for supporting nitric oxide production.

Regular physical activity is also one of the most effective ways to boost nitric oxide, as it stimulates the cells lining your blood vessels.

At the same time, nitric oxide levels can be reduced by factors such as:

• Aging
• Smoking
• Chronic inflammation
• Elevated cortisol
• Oxidative stress
• Diets low in antioxidants

Addressing these factors may help support your body’s natural ability to maintain healthy circulation.

A more complete picture

If your blood pressure hasn’t responded the way you expected, it may be worth asking a different question.

Not just: “What else can I do to lower it?”

But: “What might be driving it in the first place?”

Because when you begin to look at blood pressure through this lens — one that includes hormones, blood vessel function, and how they interact— you start to see why a one-size-fits-all approach doesn’t always work.

And more importantly, you open the door to a more targeted, effective strategy.

When blood pressure is hard to control, it’s often not because your body isn’t responding.

It’s because something important may not be fully addressed.

Sources:
Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension — The New England Journal of Medicine

Scientists reveal new blood pressure treatment that works when others fail — ScienceDaily

NO synthase inhibition increases aldosterone in humans — NIH

The role of nitric oxide in the regulation of aldosterone synthesis by adrenal glomerulosa cells — NIH